Skip to content
Medico Intercontinental logo

Medico Intercontinental

539938 BSE
Price unavailable

Medico Intercontinental (MIL) share price was ₹25.00 at the 28 Oct 2026 close; market capitalisation ₹25.01 Cr; sector Commercial Services. The share price fell 24.8% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue fell 3.0% year on year to ₹20.71 Cr and net profit was −₹4.05 Cr, against −₹2.49 Cr a year earlier (compared with Jun 2025). Promoters held 58.51% of Medico Intercontinental in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 51/100 (Average) as of 28 Oct 2026.

Close 28 Oct 2026 ₹25.00 −8.84 −26.12% 1Y

Key Fundamentals

MicrocapCommercial ServicesServices
Market Cap
₹25.01 Cr
EBITDA
₹4.20 Cr
Return on Equity
-34.37%
Debt to Equity
1.43
Book Value
₹46.89
EPS (TTM)
—
52W High
₹43.00
52W Low
₹20.61

Price-based figures as of 28 Oct 2026, 15:30 IST · TTM

Peer Comparison

Services › Commercial Services › Trading & Distributors

Redington
₹349.9516.0827,358 Cr2.691.68%12.32%19.00%1,28,312 Cr1,504 Cr
MMTC
₹51.5717.317,736 Cr3.650.00%18.27%29.75%908 Cr447 Cr
MSTC
₹565.5516.993,981 Cr4.402.82%24.16%31.29%478 Cr234 Cr
Creative Newtech
₹1,172.3023.901,760 Cr4.390.05%18.15%26.34%2,794 Cr74 Cr
Pervasive Commodities
——1,104 Cr12.250.00%-0.05%0.02%40 Cr-0 Cr
RRP Defense
——810 Cr59.900.00%53.72%74.36%12 Cr-2 Cr
Medico Intercontinental (this company)
——25 Cr0.530.41%-34.37%-1.49%85 Cr-13 Cr
Median 7 companies₹457.7517.151,760 Cr4.390.05%18.15%26.34%478 Cr74 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

51 Average
Overall score

Data confidence 93/100

Category scores

Quality Strong 68
Returns, margins, earnings quality 22% weight
Valuation Good 58
Cheap vs sector & own history 24% weight
Growth Poor 33
Sales & profit trajectory 9% weight
Financial Health Poor 18
Solvency, leverage, coverage 9% weight
Momentum Good 56
Trend strength, vol-adjusted 12% weight
Ownership Average 50
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

3
  • Stock is trading at 0.53 times its book value
  • Promoter holding has increased by 1.36% over last quarter.
  • Company's working capital requirements have reduced from 121 days to 76.2 days

Weaknesses

5
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 3.81% over past five years.
  • Company has a low return on equity of 4.06% over last 3 years.
  • Contingent liabilities of Rs.33.8 Cr.
  • Earnings include an other income of Rs.1.13 Cr.

Technical Indicators

Oscillators

Bearish

Bearish
2
Neutral
7
Bullish
0

Overall

Bearish

Bearish
8
Neutral
7
Bullish
4

Moving Averages

Bearish

Bearish
6
Neutral
0
Bullish
4

Growth Rate

Revenue Growth
-10.76% lower than 3Y

change over 1 year

Net Income Growth
-322% higher than 3Y

change over 1 year

Cash Flow Change
373%

change over 1 year

EBITDA Margin Change
-44.65%

change over 1 year Operating margin -3.33% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
24.28
17.12
14.25
15.7
19.28
36.45
18.43
21.16
21.35
20.4
19.85
22.49
20.71
Expenses
22.8
15.81
12.76
14.15
17.64
33.74
16.52
19.22
20.67
21.28
18.26
20.88
21.4
Operating Profit
1.48
1.31
1.49
1.55
1.64
2.71
1.91
1.94
0.68
-0.88
1.59
1.61
-0.69
OPM %
6.1%
7.65%
10.46%
9.87%
8.51%
7.43%
10.36%
9.17%
3.19%
-4.31%
8.01%
7.16%
-3.33%
Other Income
0.08
0.08
0.09
0.14
0.11
0.1
0.13
0.11
0.29
0.55
0.34
0.11
0.13
Interest
0.11
0.09
0.13
0.16
0.18
0.28
0.24
0.3
2.36
2.06
1.9
1.85
1.91
Depreciation
0.07
0.07
0.07
0.08
0.08
0.2
0.23
0.28
0.62
1.95
1.43
1.43
1.21
PBT
1.38
1.23
1.38
1.45
1.49
2.33
1.57
1.47
-2.01
-4.34
-1.4
-1.56
-3.68
Tax %
26.09%
29.27%
26.09%
28.28%
27.52%
29.61%
27.39%
22.45%
23.88%
4.61%
20%
51.28%
10.33%
Net Profit
1.02
0.87
1.02
1.04
1.08
1.63
1.17
1.17
-2.49
-4.51
-1.66
-2.33
-4.05
EPS (₹)
1.02
0.87
1.02
1.04
1.08
1.63
1.17
1.17
-0.68
-1.65
-0.22
-0.65
-1.45
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
0
10
82
70
74
76
71
95
84
83
Expenses
0
9
78
65
69
71
66
87
81
82
Operating Profit
0
1
4
5
5
5
6
8
3
2
OPM %
—
7%
5%
7%
7%
7%
8%
9%
3.6%
1.9%
Other Income
0
0
0
0
0
1
0
0
1
1
Interest
0
0
1
1
1
1
0
1
8
8
Depreciation
0
0
0
0
0
0
0
1
5
6
PBT
0
1
3
4
4
5
5
7
-9
-11
Tax %
40%
27%
26%
27%
27%
27%
27%
27%
19%
—
Net Profit
0
1
2
3
3
4
4
5
-11
-13
EPS (₹)
0.09
2.28
7.26
7.94
9.54
3.61
3.95
5.06
-3.2
-3.97
Div. Payout %
0%
0%
0%
0%
0%
3%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
3
3
3
3
3
10
10
10
10
Reserves
0
1
3
6
9
31
35
40
37
Borrowings
0
0
14
9
9
5
5
17
67
Other Liabilities
1
5
16
12
11
13
6
10
3
Total Liabilities
4
9
36
31
32
59
56
77
117
Fixed Assets
0
0
2
2
2
3
4
9
51
CWIP
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
3
2
Other Assets
4
9
34
28
30
56
53
65
64
Total Assets
4
9
36
31
32
59
56
77
117
Figures in ₹ Crores

Cash Flow

Particulars Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0
1
-14
6
4
-10
6
-6
17
Investing
0
0
0
-1
-1
-5
-9
-5
2
Financing
0
0
13
-5
-1
20
0
10
-16
Net Cash Flow
0
1
0
0
1
5
-3
-1
4
Free Cash Flow
0
1
-14
5
4
-11
4
-8
19
CFO/OP
-6
171
-200
138
100
-167
118
-55
629
Figures in ₹ Crores

Ratios

Particulars Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
—
237
101
94
84
157
119
124
119
Inventory Days
—
26
46
58
47
52
69
42
87
Days Payable
—
201
74
67
50
67
30
36
82
Cash Conversion Cycle
—
62
74
85
81
143
158
130
124
Working Capital Days
—
78
74
68
66
132
134
154
76
ROCE %
—
28%
36%
25%
25%
17%
12%
13%
-2%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Medico Intercontinental insights

59 extracted metrics + investor summaries across FY15–FY27.

Shareholding Pattern

Promot.58.51%Others6.10%Public35.39%As ofSep 2026

Documents

Frequently Asked Questions about Medico Intercontinental

What does Medico Intercontinental Ltd do?
Incorporated in 1914, Medico Intercontinental Ltd is engaged in trading of Pharmaceutical products[1]
Where is Medico Intercontinental Ltd (MIL) listed?
Medico Intercontinental Ltd trades under code 539938 on the BSE.
Which sector does Medico Intercontinental Ltd belong to?
Medico Intercontinental Ltd is classified under the Commercial Services sector, in the Trading & Distributors industry.
What is the market capitalisation of Medico Intercontinental Ltd?
Medico Intercontinental Ltd has a market capitalisation of ₹25.01 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the 52-week high and low of Medico Intercontinental Ltd?
Over the last 52 weeks Medico Intercontinental Ltd has traded between ₹20.61 and ₹43 as of 28 Oct 2026.
Does Medico Intercontinental Ltd pay dividends?
Medico Intercontinental Ltd has a dividend yield of 0.40%.
What is the Return on Equity (ROE) of Medico Intercontinental Ltd?
Medico Intercontinental Ltd reported a return on equity of -34.37%. Its debt-to-equity ratio is 1.43.

Company Information

Incorporated in 1914, Medico Intercontinental Ltd is engaged in trading of Pharmaceutical products[1]

Website medicointercontinental.com
CEO Mr. Samir Dilipkumar Shah
Employees 38
Listed 2019-06-21
Face Value ₹ 10
Shares Outstanding 1,00,04,221

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/539938.md for Medico Intercontinental Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Commercial Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month